We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$25.6B
AUM Growth
+$29.8M
Cap. Flow
-$1.17B
Cap. Flow %
-4.59%
Top 10 Hldgs %
14.11%
Holding
1,418
New
109
Increased
422
Reduced
606
Closed
147

Top Buys

Rank Stock Value
1
JMIA
Jumia Technologies
JMIA
+$130M
2
NXPI icon
NXP Semiconductors
NXPI
+$55.3M
3
AZO icon
AutoZone
AZO
+$42.3M
4
ALC icon
Alcon
ALC
+$35.7M
5
INTU icon
Intuit
INTU
+$33.7M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$126M
2
BIDU icon
Baidu
BIDU
+$83.8M
3
ROK icon
Rockwell Automation
ROK
+$76.1M
4
AMZN icon
Amazon
AMZN
+$74.9M
5
XLNX
Xilinx Inc
XLNX
+$56.7M

Sector Composition

Rank Sector Weight
1 Technology 23.13%
2 Healthcare 15.25%
3 Consumer Discretionary 10.67%
4 Financials 10.37%
5 Industrials 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YEXT icon
451
Yext
YEXT
$573M
$10.5M 0.04%
520,778
+60,631
+13% +$1.25M
LOGI icon
452
Logitech
LOGI
$14.8B
$10.4M 0.04%
262,665
+37,738
+17% +$1.47M
TGNA
453
DELISTED
TEGNA Inc
TGNA
$10.2M 0.04%
674,269
-94,522
-12% -$1.46M
COLD icon
454
Americold
COLD
$4.21B
$10.2M 0.04%
314,834
+135,262
+75% +$4.29M
STRA icon
455
Strategic Education
STRA
$1.98B
$10.2M 0.04%
57,134
-10,310
-15% -$1.69M
BPMC
456
DELISTED
Blueprint Medicines
BPMC
$10.2M 0.04%
107,736
-18,054
-14% -$1.49M
ENB icon
457
Enbridge
ENB
$120B
$10.1M 0.04%
280,437
+61,733
+28% +$2.25M
ALLE icon
458
Allegion
ALLE
$13.5B
$10M 0.04%
90,834
DEI icon
459
Douglas Emmett
DEI
$2.05B
$9.99M 0.04%
250,719
-126,820
-34% -$5.2M
TSN icon
460
Tyson Foods
TSN
$21.5B
$9.98M 0.04%
123,555
+111,455
+921% +$8.59M
MFC icon
461
Manulife Financial
MFC
$73B
$9.93M 0.04%
546,086
+511,700
+1,488% +$9.1M
UI icon
462
Ubiquiti
UI
$31.6B
$9.91M 0.04%
75,400
+10,400
+16% +$1.51M
FDS icon
463
Factset
FDS
$10B
$9.89M 0.04%
+34,508
New +$9.55M
TRI icon
464
Thomson Reuters
TRI
$46.4B
$9.86M 0.04%
145,166
-124,328
-46% -$8.23M
YUMC icon
465
Yum China
YUMC
$15.7B
$9.8M 0.04%
212,134
+4,700
+2% +$204K
TTD icon
466
Trade Desk
TTD
$8.97B
$9.75M 0.04%
428,000
+233,000
+119% +$5.01M
SLB icon
467
SLB Ltd
SLB
$72.7B
$9.73M 0.04%
244,936
-7,356
-3% -$297K
A icon
468
Agilent Technologies
A
$39.6B
$9.68M 0.04%
129,640
+105,373
+434% +$7.81M
CBLK
469
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$9.53M 0.04%
570,000
+70,000
+14% +$1.07M
CWB icon
470
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.41B
$9.49M 0.04%
179,580
+200
+0.1% +$10.5K
XPO icon
471
XPO
XPO
$23.4B
$9.48M 0.04%
474,229
+14,414
+3% +$294K
D icon
472
Dominion Energy
D
$62.1B
$9.43M 0.04%
121,970
+1,651
+1% +$126K
AIZ icon
473
Assurant
AIZ
$13.9B
$9.37M 0.04%
88,100
+85,800
+3,730% +$8.48M
SRPT icon
474
Sarepta Therapeutics
SRPT
$1.64B
$9.36M 0.04%
61,585
-20,776
-25% -$2.52M
MIME
475
DELISTED
Mimecast Limited
MIME
$9.34M 0.04%
200,000

Similar funds

Axa's Q2 2019 Portfolio in Review

As of Q2 2019, Axa held 1,418 positions worth $25.6B, up 0.12% from $25.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa withdrew a net $1.17B in Q2 2019, closing 147 positions and reducing 606 holdings. Its most notable exit was Foot Locker, an estimated $10.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Axa opened a new position in Jumia Technologies worth $119M.

  • Axa's largest Q2 2019 buy was Jumia Technologies: 4,502,527 shares worth $119M.
  • Axa added most to NXP Semiconductors in Q2 2019, an estimated $55.3M increase.
  • Axa's biggest Q2 2019 reduction was Linde, cutting an estimated $126M.
  • Axa fully exited Foot Locker in Q2 2019, selling an estimated $10.1M.
  • Axa's ten largest holdings make up 14% of its $25.6B portfolio in Q2 2019.
  • Axa opened 109 new positions and closed 147 in Q2 2019.
  • Axa's portfolio value rose 0.12% quarter-over-quarter to $25.6B.

Based on Axa's 13F filing for Q2 2019, filed 13 Aug 2019.